BioMolecular Networks in Antibiotic Resistance Evolution
抗生素耐药性进化中的生物分子网络
基本信息
- 批准号:6907605
- 负责人:
- 金额:$ 14.09万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2005
- 资助国家:美国
- 起止时间:2005-06-01 至 2009-04-30
- 项目状态:已结题
- 来源:
- 关键词:
项目摘要
DESCRIPTION (provided by applicant): The overall objective of the proposed K25 career development program is to provide a period of mentored didactic and research training that will allow the candidate to focus his quantitative background in metabolic engineering on research questions of health and disease. The specific objectives are i) to receive didactic training in bacterial pathogenesis, ii) to obtain mentored guidance in clinical microbiology, molecular evolution, and microbial evolution research, and iii) to develop a foundation for future research endeavors that use, develop, and combine genomics and bioinformatics tools to better understand bio-molecular network evolution within the context of bacterial pathogenesis and antibiotic resistance.
Research Description. Fluoroquinolone resistance is known to occur in a step wise fashion often involving a combination of decreased drug accumulation or target affinity. The unusually rapid adaptability and surprisingly high number of transport related genes in P. aeruginosa has complicated efforts to understand the emergence of fluoroquinolone resistance in this organism. For example, there are 88 genes in P. aeruginosa with known or putative efflux functions. The relevance of each of these and other potential cryptic resistance genes in the evolution of fluoroquinolone resistance is not known. The 1st major objective of this study is to identify, using an unbiased, genome-wide approach, and characterize cryptic fluoroquinolone resistance genes in P. aeruginosa with respect to the relative costs and benefits to biological fitness and virulence associated with each gene (Aims 1-2). Using network theory, we hypothesize that resistance mutations in genes with a large number biological interactions will impose a higher cost than mutations in genes with a small number of biological interactions. The 2nd major objective of this study is to further develop several genomics/bioinformatics tools that will allow us to test this hypothesis (Aims 3-4).
拟议的K25职业发展计划的总体目标是提供一段时间的指导教学和研究培训,使候选人能够将代谢工程的定量背景集中在健康和疾病的研究问题上。具体目标是:i)接受细菌发病机制的教学培训,ii)获得临床微生物学,分子进化和微生物进化研究的指导,iii)为未来使用,开发和联合收割机和生物信息学工具的研究工作奠定基础,以更好地了解细菌发病机制和抗生素耐药性背景下的生物分子网络进化。
研究描述。已知氟喹诺酮耐药性以逐步方式发生,通常涉及药物蓄积或靶向亲和力降低的组合。铜绿假单胞菌中异常快速的适应性和令人惊讶的高数量的转运相关基因使得理解该生物体中氟喹诺酮耐药性的出现的努力变得复杂。例如,铜绿假单胞菌中有88个基因具有已知或推定的外排功能。这些基因和其他潜在的隐性耐药基因与氟喹诺酮耐药演变的相关性尚不清楚。本研究的第一个主要目的是使用无偏倚的全基因组方法识别并表征铜绿假单胞菌中隐藏的氟喹诺酮类耐药基因,以及与每个基因相关的生物适应性和毒力的相对成本和效益(目的1-2)。使用网络理论,我们假设,具有大量生物相互作用的基因中的抗性突变将比具有少量生物相互作用的基因中的突变产生更高的成本。本研究的第二个主要目标是进一步开发几种基因组学/生物信息学工具,使我们能够验证这一假设(目标3-4)。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
RYAN T GILL其他文献
RYAN T GILL的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('RYAN T GILL', 18)}}的其他基金
BioMolecular Networks in Antibiotic Resistance Evolution
抗生素耐药性进化中的生物分子网络
- 批准号:
7058735 - 财政年份:2005
- 资助金额:
$ 14.09万 - 项目类别:
BioMolecular Networks in Antibiotic Resistance Evolution
抗生素耐药性进化中的生物分子网络
- 批准号:
7394397 - 财政年份:2005
- 资助金额:
$ 14.09万 - 项目类别:
BioMolecular Networks in Antibiotic Resistance Evolution
抗生素耐药性进化中的生物分子网络
- 批准号:
7215720 - 财政年份:2005
- 资助金额:
$ 14.09万 - 项目类别:
Using Genomics to Identify Antibiotic Sensitivity Genes
利用基因组学识别抗生素敏感性基因
- 批准号:
6673512 - 财政年份:2003
- 资助金额:
$ 14.09万 - 项目类别:
Using Genomics to Identify Antibiotic Sensitivity Genes
利用基因组学识别抗生素敏感性基因
- 批准号:
6741835 - 财政年份:2003
- 资助金额:
$ 14.09万 - 项目类别:
相似海外基金
Can antibiotics disrupt biogeochemical nitrogen cycling in the coastal ocean?
抗生素会破坏沿海海洋的生物地球化学氮循环吗?
- 批准号:
2902098 - 财政年份:2024
- 资助金额:
$ 14.09万 - 项目类别:
Studentship
The role of RNA repair in bacterial responses to translation-inhibiting antibiotics
RNA修复在细菌对翻译抑制抗生素的反应中的作用
- 批准号:
BB/Y004035/1 - 财政年份:2024
- 资助金额:
$ 14.09万 - 项目类别:
Research Grant
Metallo-Peptides: Arming Cyclic Peptide Antibiotics with New Weapons to Combat Antimicrobial Resistance
金属肽:用新武器武装环肽抗生素以对抗抗菌素耐药性
- 批准号:
EP/Z533026/1 - 财政年份:2024
- 资助金额:
$ 14.09万 - 项目类别:
Research Grant
Towards the sustainable discovery and development of new antibiotics
迈向新抗生素的可持续发现和开发
- 批准号:
FT230100468 - 财政年份:2024
- 资助金额:
$ 14.09万 - 项目类别:
ARC Future Fellowships
DYNBIOTICS - Understanding the dynamics of antibiotics transport in individual bacteria
DYNBIOTICS - 了解抗生素在单个细菌中转运的动态
- 批准号:
EP/Y023528/1 - 财政年份:2024
- 资助金额:
$ 14.09万 - 项目类别:
Research Grant
Engineering Streptomyces bacteria for the sustainable manufacture of antibiotics
工程化链霉菌用于抗生素的可持续生产
- 批准号:
BB/Y007611/1 - 财政年份:2024
- 资助金额:
$ 14.09万 - 项目类别:
Research Grant
The disulfide bond as a chemical tool in cyclic peptide antibiotics: engineering disulfide polymyxins and murepavadin
二硫键作为环肽抗生素的化学工具:工程化二硫多粘菌素和 murepavadin
- 批准号:
MR/Y033809/1 - 财政年份:2024
- 资助金额:
$ 14.09万 - 项目类别:
Research Grant
Reinforcing the battle at the bacterial cell wall: Structure-guided characterization and inhibition of beta-lactam antibiotic resistance signalling mechanisms
加强细菌细胞壁的战斗:β-内酰胺抗生素耐药信号机制的结构引导表征和抑制
- 批准号:
480022 - 财政年份:2023
- 资助金额:
$ 14.09万 - 项目类别:
Operating Grants
Generative machine learning for narrow spectrum antibiotic discovery against Acinetobacter baumannii
生成机器学习用于发现针对鲍曼不动杆菌的窄谱抗生素
- 批准号:
477936 - 财政年份:2023
- 资助金额:
$ 14.09万 - 项目类别:
Operating Grants
Prevention of Infections in Cardiac Surgery (PICS): a cluster-randomized factorial cross-over trial
心脏手术中感染的预防 (PICS):整群随机因子交叉试验
- 批准号:
498291 - 财政年份:2023
- 资助金额:
$ 14.09万 - 项目类别:
Operating Grants